Experts in the field discuss the challenges of diagnosing amyloidosis, the significance of cardio-oncology, and the current therapies available. They emphasize the importance of a multidisciplinary team in treating patients and highlight the critical role of early diagnosis and collaboration between specialists for successful management.

Experts Ashutosh Wechalekar and Vaishali Sanchorawala discuss updates in the diagnosis and treatment of amyloidosis at the 65th ASH Annual Meeting. They cover topics such as a new diagnostic test, the use of Bellantabap as a therapy, the safety and efficacy of Biltamimab, and the differences between staging systems for amyloidosis.